CLINICAL_TRIALS
trial_result
· 2018-03-22
Clinical Trial Update: Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis [Phase 3]
Summary
A Phase 3 pilot trial evaluated certolizumab pegol for Interstitial Cystitis. Results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ICStudy, LLC | Conditions: Cystitis, Interstitial | Phase 3 | Status: COMPLETED | Results posted: 2018-03-22